CARL
Carlsmed, Inc.
14.30$
+3.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | +11.6% | -7.9% | +153.2% | -3.5% | -8.7% | -0.5% | |
| – | – | – | – | – | +9.8% | -14.7% | +184.6% | -3.6% | -8.9% | -5.0% | |
| – | -2.0% | – | – | – | +8.2% | -22.9% | +244.7% | -25.6% | -14.9% | -36.7% | |
| – | -2.0% | – | – | – | +8.2% | -22.9% | +244.7% | -4.8% | -11.6% | -8.0% | |
| – | – | – | – | – | +20.0% | +19.6% | +16.3% | +0.6% | +8.0% | +12.3% | |
| – | – | – | – | – | +26.7% | -15.3% | +25.5% | +37.7% | +11.8% | +10.3% | |
| – | -83.6% | – | – | – | +9.8% | +1.4% | -79.3% | +10.8% | -15.1% | +28.0% | |
| – | – | – | – | – | -5.2% | +13.4% | +15.2% | +30.7% | -32.0% | +27.6% | |
| – | – | – | – | – | +3.3% | +23.1% | +15.8% | +13.8% | +3.2% | -9.4% | |
| – | – | – | – | – | +6.9% | +0.1% | +3.5% | +67.7% | -34.1% | +25.5% | |
| – | – | – | – | – | +0.1% | +0.1% | +0.1% | -0.6% | +0.1% | +0.1% | |
| – | – | – | – | – | – | – | – | -7.3% | -6.7% | -8.7% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -84.9% | +1.4% | +13.2% | +477.7% | -27.7% | -76.1% | +359.3% | -32.5% | +88.7% | +1.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.